|
1
|
Morrison SJ and Scadden DT: The bone
marrow niche for haematopoietic stem cells. Nature. 505:327–334.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anthony BA and Link DC: Regulation of
hematopoietic stem cells by bone marrow stromal cells. Trends
Immunol. 35:32–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Hendrix A, Hernot S, Lemaire M, De
Bruyne E, Van Valckenborgh E, Lahoutte T, De Wever O, Vandenrkerken
K and Menu E: Bone marrow stroma cell-derived exosomes as
communications in drug resistance in multiple myeloma cells. Blood.
124:555–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bernardo ME and Fibbe WE: Mesenchymal
stromal cells: Sensors and switches of inflammation. Cell Stem
Cell. 13:392–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nauta AJ and Fibbe WE: Immunomodulatory
properties of mesenchymal stromal cells. Blood. 110:3499–3506.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whiteside TL: Exosome and mesenchymal stem
cell cross-talk in the tumor microenvironment. Semin Immunol.
35:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin LY, Du LM, Cao K, Huang Y, Yu PF,
Zhang LY, Li FY, Wang Y and Shi YF: Tumor cell-derived exosomes
endow mesenchymal stromal cells with tumour-promotion capabilities.
Oncogene. 35:6038–6042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gebert LFR and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Makarova JA, Shkumikov MU, Wicklein D,
Lange T, Samatov TR, Turchinovich AA and Tonevitsky AG:
Intracellular and extracellular microRNA: An update on localization
and biological role. Prog Histochem Cytochem. 51:33–49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohyashiki JH, Umezu T and Ohyashiki K:
Extracellular vesicle-mediated cell-cell communication in
haematological neoplasms. Philos Trans R Soc Lond B Biol Sci.
373(pii): 201604842018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azmi AS, Bao B and Sarkar FH: Exosomes in
cancer development, metastasis and drug resistance: A comprehensive
review. Cancer Metastasis Rev. 32:623–642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang X, Li Y, Zou L and Zhu Z: Role of
exosomes in crosstalk between cancer-associated fibroblasts and
cancer cells. Front Oncol. 9:3562019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greenberg PL, Tuechler H, Schanz J, Sanz
G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus
F, et al: Revised international prognostic scoring system for
myelodysplastic syndromes. Blood. 120:2454–2465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greenberg PL, Stone RM, Al-Kli A, Barta
SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern
AE, et al: Myelodysplastic syndrome, version 2. 2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw. 15:60–87.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Azuma K, Umezu T, Imanishi S, Asano M,
Yoshizawa S, Katagiri S, Ohyashiki K and Ohyashiki JH: Genetic
variations of bone marrow mesenchymal stromal cells derive from
acute leukemia and myelodysplastic syndrome by targeted deep
sequencing. Leuk Res. 62:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Umezu T, Ohyashiki K, Kuroda M and
Ohyashiki JH: Leukemia cell to endothelial cell communication via
exosomal miRNAs. Oncogene. 32:2747–2755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshizawa S, Umezu T, Saitoh Y, Gotoh M,
Akahane D, Kobayashi C, Ohyashiki JH and Ohyashiki K: Exosomal
miRNA signatures for late-onset acute graft-versus host disease in
allogeneic hematopoietic stem cell transplantation. Int J Mol Sci.
19(pii): E24932018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Umezu T, Tadokoro H, Azuma K, Yoshizawa S,
Ohyashiki K and Ohyashiki JH: Exosomal miR-135b shed from hypoxic
multiple myeloma cells enhances angiogenesis by targeting
factor-inhibiting HIF-1. Blood. 124:3748–3757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paggetti J, Haderk F, Seiffert M, Janji B,
Distler U, Ammerlaan W, Kim YJ, Adam J, Lichter P, Solary E, et al:
Exosomes released by chronic lymphocytic leukemia cells induce the
transition of stromal cells into cancer-associated fibroblasts.
Blood. 126:1106–1117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Orimo A and Weinberg RA: Stromal
fibroblasts in cancer: A novel tumor-promoting cell type. Cell
Cycle. 5:1597–1601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Veirman K, Rao L, De Bruyne E, Menu E,
Van Valckenborgh E, Van Riet I, Frassanito MA, Di Marzo L, Vacca A
and Vanderkerken K: Cancer associated fibroblasts and tumor growth:
Focus on multiple myeloma. Cancers (Basel). 6:1363–1381. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ozdogan H, Gur Dedeoglu B, Oztemur
Islakoglu Y, Aydos A, Kose S, Ataly A, Yegin ZA, Avcu F, Uckan
Cetinkaya D and Ihan O: DICER1 gene and miRNA dysregulation in
mesenchymal stem cells of patients with myelodysplastic syndrome
and acute myeloblastic leukemia. Leuk Res. 63:62–71. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Wu D, Fei C, Guo J, Gu S, Xu F,
Zhang Z, Wu L, Li X and Chang C: Down-regulation of Dicer1 promotes
cellular senescence and decreases the differentiation and stem
cell-supporting capacities of mesenchymal stromal cells in patient
with myelodysplastic syndrome. Haematologica. 100:194–204. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Umezu T, Imanishi S, Azuma K, Kobayashi C,
Yoshizawa S, Ohyashiki K and Ohyashiki JH: Replenishing exosomes
from older bone marrow stromal cells with miR-340 inhibits
myeloma-related angiogenesis. Blood Adv. 1:812–823. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang
Y, Liu L, Liu W and Liu X: MicroRNA-101 inhibits the proliferation
and invasion of bladder cancer cells via targeting c-FOS. Mol Med
Rep. 14:2651–2656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng Z and Zhang Y: Methyl jasmonate
induces the apoptosis of human colorectal cancer cells via down
regulation of EZH2 expression by microRNA-101. Mol Med Rep.
15:957–962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guan H, Dai Z, Ma Y, Wang Z, Liu X and
Whang X: MicroRNA-101 inhibits cell proliferation and induces
apoptosis by targeting EYA1 in breast cancer. Int J Mol Med.
37:1643–1651. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng G, Teng Y, Huang F, Nie W, Zhu I,
Huang W and Xu H: MicroRNA-101 inhibits the migration and invasion
of intrahepatic cholangiocarcinoma cells via direct suppression of
vascular endothelial growth factor-C. Mol Med Rep. 12:7079–7085.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li G, Yang F, Gu S, Li Z and Xue M:
MicroRNA-101 induces apoptosis in cisplatin-resistant gastric
cancer cells by targeting VEGF-C. Mol Med Rep. 13:572–578. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzales-Aloy E, Connerty P, Salik B, Liu
B, Woo AW, Haber M, Norris MD, Wand J and Wand JY: MiR-101
suppresses the development of MLL-rearranged acute myeloid
leukemia. Haematologica. 104:e296–e300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qian L, Zhang W, Lei B, He A, Ye L, Li X
and Don X: MicroRNA-101 regulates T-cell acute lymphoblastic
leukemia progression and chemotherapeutic sensitivity by targeting
Notch1. Oncol Rep. 36:2511–2526. 2015. View Article : Google Scholar
|
|
34
|
Ghobrial IM, Detappe A, Anderson KC and
Steensma SP: The bone-marrow niche in MDS and MGUS: Implications
for AML and MM. Nat Rev Clin Oncol. 15:219–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Flores-Figueroa E, Arana-Trejo RM,
Gutierrez-Espindola G, Perez-Cabrera A and Mayani H: Mesenchymal
stem cells in myelodysplastic syndromes: Phenotypic and cytogenetic
characterization. Leuk Res. 29:215–224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blau O, Hofmann WK, Baldus CD, Thiel G,
Serbent GV, Schumann E, Thiel E and Blau IW: Chromosomal
aberrations in bone marrow mesenchymal stroma cells from patients
with myelodysplastic syndrome and acute myeloblastic leukemia. Exp
Hematol. 35:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Poon Z, Dighe N, Venkatesan SS, Cheung
AMS, Fan X, Bari S, Hota M, Ghosh S and Hwang WYK: Bone marrow MSCs
in MDS: Contribution towards dysfunctional hematopoiesis and
potential targets for disease response to hypomethylating therapy.
Leukemia. 33:1487–1500. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
WMA declaration of Helsinki: Ethical
principles for medical research involving human subjects. Retrieved
from. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/World
Medical Association; 2013
|
